LOREEVXRHCP.COM: Keyword Density Checker

Total words: 4407 | 2-word phrases: 1143 | 3-word phrases: 1291 | 4-word phrases: 1330

PAGE INFO

Title	Try to keep the title under 60 characters (47 characters) HCP \| LOREEV XR™ (lorazepam) extended-release
Description	Try to keep the meta description between 50 - 160 characters (60 characters) Once-Daily LOREEV XRTM (lorazepam) extended-release capsules
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (117 characters) Help patients gain control of their day.Treat their anxiety with LOREEV XR®, a once-daily extended-release capsule.1

#	Keyword	Frequency	Density
1	almatica pharma llc	6	0.46%
2	loreev xr is	4	0.31%
3	information almatica pharma	3	0.23%
4	of loreev xr	3	0.23%
5	in patients with	3	0.23%
6	misuse and addiction	3	0.23%
7	with loreev xr	2	0.15%
8	loreev xr yellow	2	0.15%
9	abuse misuse and	2	0.15%
10	ssris and snris	2	0.15%
11	is not recommended	2	0.15%
12	at steady state	2	0.15%
13	information abbvie inc	2	0.15%
14	prescribing information abbvie	2	0.15%
15	interactions due to	2	0.15%
16	loreev xr for	2	0.15%
17	abbvie inc 2023	2	0.15%
18	lorazepam is metabolized	2	0.15%
19	other cns depressants	2	0.15%
20	fdc yellow no	2	0.15%
21	yellow no 5	2	0.15%
22	lorazepam ir tablets	2	0.15%
23	concomitant use with	2	0.15%
24	use with opioids	2	0.15%
25	loreev xr red	2	0.15%
26	loreev xr purple	2	0.15%
27	extendedrelease beads begin	2	0.15%
28	prescribing information almatica	2	0.15%
29	throughout the day	2	0.15%
30	pharma llc 2023	2	0.15%

#	Keyword	Frequency	Density
1	information almatica pharma llc	3	0.23%
2	symptoms of respiratory depression	2	0.15%
3	concomitant use with opioids	2	0.15%
4	abuse misuse and addiction	2	0.15%
5	extendedrelease beads begin to	2	0.15%
6	prescribing information almatica pharma	2	0.15%
7	information abbvie inc 2023	2	0.15%
8	prescribing information abbvie inc	2	0.15%
9	almatica pharma llc 2023	2	0.15%
10	fdc yellow no 5	2	0.15%
11	use and are more	1	0.08%
12	benzodiazepine use and are	1	0.08%
13	occasionally been reported during	1	0.08%
14	have occasionally been reported	1	0.08%
15	reactions have occasionally been	1	0.08%
16	paradoxical reactions have occasionally	1	0.08%
17	and are more likely	1	0.08%
18	risk of paradoxical reactions	1	0.08%
19	are more likely to	1	0.08%
20	more likely to occur	1	0.08%
21	for us healthcare professionals	1	0.08%
22	to occur in the	1	0.08%
23	likely to occur in	1	0.08%
24	antidepressant therapy risk of	1	0.08%
25	occur in the elderly	1	0.08%
26	in the elderly if	1	0.08%
27	the elderly if this	1	0.08%
28	occurs discontinue loreev xr	1	0.08%
29	discontinue loreev xr allergic	1	0.08%
30	loreev xr allergic reactions	1	0.08%
31	xr allergic reactions to	1	0.08%
32	allergic reactions to fdc	1	0.08%
33	reactions to fdc yellow	1	0.08%
34	to fdc yellow no	1	0.08%
35	yellow no 5 tartrazine	1	0.08%
36	tartrazine loreev xr 1	1	0.08%
37	therapy risk of paradoxical	1	0.08%
38	should not be used	1	0.08%
39	adequate antidepressant therapy risk	1	0.08%
40	psychosis preexisting depression may	1	0.08%

#	URL	Whois	Check
1	http://www.loreevxr.com/prescribing-information.pdf	Whois	loreevxr.com
2	http://www.loreevxr.com/medication-guide.pdf	Whois	loreevxr.com
3	https://www.loreevxr.com	Whois	loreevxr.com
4	http://www.loreevxr.com/prescribing-information.pdf	Whois	loreevxr.com
5	http://www.loreevxr.com/medication-guide.pdf	Whois	loreevxr.com
6	http://www.fda.gov/medwatch	Whois	fda.gov
7	https://www.almatica.com/	Whois	almatica.com
8	https://www.almatica.com/privacy-policy/	Whois	almatica.com
9	https://www.almatica.com/terms-of-use/	Whois	almatica.com
10	https://www.almatica.com/about-us/contact-us/	Whois	almatica.com
11	https://www.almatica.com	Whois	almatica.com